메뉴 건너뛰기




Volumn 4, Issue 3, 2001, Pages 296-300

The development of pharmacogenomic models to predict drug response

Author keywords

ADME Tox; Medicine response profile; Principle component analysis; Single nucleotide polymorphism

Indexed keywords

BIOSTATISTICS; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DESIGN; DRUG RESPONSE; GENE MAPPING; HEALTH CARE; MARKER GENE; PHARMACOGENOMICS; PREDICTION; PUBLICATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT PLANNING;

EID: 0034981437     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (38)
  • 1
    • 0003364848 scopus 로고    scopus 로고
    • The Genome International Sequencing Consortium: The human genome
    • (2001) Nature , vol.409 , pp. 813-958
  • 5
    • 0033574303 scopus 로고    scopus 로고
    • Drug firms to create public database of genetic mutations
    • (1999) Science , vol.284 , pp. 406-407
    • Marshall, E.1
  • 13
    • 0033059209 scopus 로고    scopus 로고
    • Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
    • (1999) Nature Genet , vol.22 , pp. 168-170
    • Drazen, J.M.1
  • 23
    • 0032921441 scopus 로고    scopus 로고
    • Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease
    • (1999) J Psychiatr Neurosci , vol.24 , pp. 147-153
    • Poirier, J.1
  • 38
    • 0034660560 scopus 로고    scopus 로고
    • Pharmacogenetics and the practice of medicine
    • (2000) Nature , vol.405 , pp. 857-865
    • Roses, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.